News & Perspective

Feb 06, 2019

Feb 06, 2019
US Capitol

Letter urges congressional action to stimulate antibiotic development

The push from drug developers and health groups asks Congress to take steps to prevent a public health crisis due to antibiotic resistance with few promising drugs in the pipeline.

Jan 10, 2017

Jan 10, 2017

Zika mRNA vaccine enters clinical trial; Angola reports cases

In other Zika developments, the CDC released new fact sheets for pregnant women about the complexities involved in Zika testing.

Dec 21, 2015

Dec 21, 2015
DC skyline

Infectious disease efforts see gains in 2016 budget approval

The NIH sees its biggest boost in 12 years, and other public health initiatives benefit, too.

Sep 30, 2015

Sep 30, 2015
Ebola contact tracing

Guinea reports 4 Ebola cases; WHO details response reforms

In other developments, the HHS announced more funding for a rapid Ebola test.

Jul 02, 2015

Jul 02, 2015
Vaccine vials

GSK upgrade delays supply of adjuvanted H5N1 vaccine

A recommendation for occupational use was tabled until the vaccine becomes available.

Feb 03, 2015

Feb 03, 2015
Pills and money

Infectious-disease programs fare well in Obama's 2016 budget

Highlights include funds for antibiotic resistance, bioterrorism preparedness, and a unified food safety agency.

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»